Pharmaceuticals

Showing 1 - 2 out of 2
Front of the Astellas building

Astellas

$56 million proactive repositioning of existing office into a state-of-the-art life sciences facility for new tenant.
External of a building owned by W. P. Carey, leased to Apotex.

Apotex

$468 million of sale-leaseback capital used to finance a portion of a PE firm's buyout of global pharmaceutical company.